• Treffer 2 von 63
Zurück zur Trefferliste

Daily non‐invasive haemodynamic telemonitoring for efficacy evaluation of MitraClip® implantation in patients with advanced systolic heart failure

  • Aim: Patients with advanced systolic chronic heart failure frequently suffer from progressive functional mitral regurgitation. We report our initial experience in patients with an implanted pulmonary artery pressure (PAP) sensor, who developed severe mitral regurgitation, which was treated with the MitraClip system. We non‐invasively compared changes in PAP values in patients after MitraClip with PAP changes in patients without MitraClip. Methods and results: Among 28 patients with New York Heart Association III heart failure with implanted PAP sensor for haemodynamic telemonitoring from a single centre, four patients (age 66 ± 6 years, left ventricular ejection fraction 21 ± 3%, and cardiac index 1.8 ± 0.3) received a MitraClip procedure and were compared with 24 patients (age 72 ± 8 years, left ventricular ejection fraction 26 ± 9.9%, and cardiac index 2.0 ± 1.0) without MitraClip procedure in a descriptive manner. Ambulatory PAP values were followed for 90 days in both groups. In comparison with the PAP values 4 weeks before MitraClip procedure, PAP was profoundly reduced in all four patients after 30 days (ΔPAPmean −11 ± 5, ΔPAPdiast −7 ± 3 mmHg, P < 0.02) as well as after 90 days (ΔPAPmean −6.3 ± 6, ΔPAPdiast −1 ± 3 mmHg). Reductions in PAP were accompanied by a profound reduction in N terminal pro brain natriuretic peptide as well as clinical and echocardiographic improvement. When analysing the dynamics with a regression model, reductions in all PAP values were significantly greater after MitraClip compared with conservative haemodynamic monitoring (P < 0.001). Conclusions: The efficacy of the interventional MitraClip procedure on clinical symptoms can be confirmed by haemodynamic telemonitoring. Thus, daily non‐invasive haemodynamic telemonitoring allows, for the first time, for a continuous assessment of the haemodynamic efficacy of novel therapies in patients with chronic heart failure.

Volltext Dateien herunterladen

Metadaten exportieren

Metadaten
Verfasserangaben:Ester Herrmann, Andreas Ecke, Eva HerrmannORCiDGND, Nina Eissing, Stephan Fichtlscherer, Andreas M. ZeiherORCiDGND, Birgit AßmusORCiDGND
URN:urn:nbn:de:hebis:30:3-486059
DOI:https://doi.org/10.1002/ehf2.12303
ISSN:2055-5822
Pubmed-Id:https://pubmed.ncbi.nlm.nih.gov/29893475
Titel des übergeordneten Werkes (Englisch):ESC heart failure
Verlag:Wiley
Verlagsort:Chichester
Dokumentart:Wissenschaftlicher Artikel
Sprache:Englisch
Jahr der Fertigstellung:2018
Datum der Erstveröffentlichung:12.06.2018
Veröffentlichende Institution:Universitätsbibliothek Johann Christian Senckenberg
Datum der Freischaltung:15.01.2019
Freies Schlagwort / Tag:Chronic heart failure; MitraClip; Pulmonary artery pressure; Remote monitoring
Jahrgang:5
Ausgabe / Heft:5
Seitenzahl:8
Erste Seite:780
Letzte Seite:787
Bemerkung:
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
HeBIS-PPN:446478199
Institute:Medizin / Medizin
Exzellenzcluster / Exzellenzcluster Herz-Lungen-System
DDC-Klassifikation:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Lizenz (Deutsch):License LogoCreative Commons - Namensnennung-Nicht kommerziell - Keine Bearbeitung 4.0